Please log in.

Lost your password?

Create an account

EPI-743 Leighs Syndrome Trial Update April 2013

April 15, 2013 by cynthia

EPI-743 is a new drug based on vitamin E and has been shown to improve the function of cells with mitochondrial problems. http://www.mitoaction.org/blog/epi-743-leighs-syndrome-trial-update-april-2013   For more¬†information: ClinicalTrials.gov – a service of the U.S. National Institutes of Health http://www.clinicaltrials.gov/ct2/show/NCT01642056 Edison Pharma Lands Dainippon in Potential $545M Japan Deal http://www.bioworld.com/content/edison-pharma-lands-dainippon-potential-545m-japan-deal-0  

Clinical trial for Mitochondrial Respiratory Chain Diseases

January 26, 2012 by Yurina Ichikawa

A link about the clinical trial led by Principal Investigator Dr. Gregory Enns (Stanford University). The purpose of this trial is to test the safety and efficacy of the drug, EPI-743, in patients affected with mitochondrial respiratory chain diseases. The trial is currently in phase II. http://www.clinicaltrials.gov/ct2/show/NCT01370447?cond=%22Leigh+syndrome%22&rank=1